HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictors of anti-vascular endothelial growth factor treatment responses in macular edema following central vein occlusion.

AuthorsPeirong Huang, Zhengyu Song, Xiaodong Sun
JournalChinese medical journal (Chin Med J (Engl)) Vol. 127 Issue 16 Pg. 3019-23 ( 2014) ISSN: 2542-5641 [Electronic] China
PMID25131244 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Aptamers, Nucleotide
  • Recombinant Fusion Proteins
  • Vascular Endothelial Growth Factor A
  • aflibercept
  • pegaptanib
  • Bevacizumab
  • Receptors, Vascular Endothelial Growth Factor
  • Ranibizumab
Topics
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Aptamers, Nucleotide (therapeutic use)
  • Bevacizumab
  • Humans
  • Macular Edema (drug therapy)
  • Ranibizumab
  • Receptors, Vascular Endothelial Growth Factor (therapeutic use)
  • Recombinant Fusion Proteins (therapeutic use)
  • Retinal Vein Occlusion (drug therapy)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)
  • Visual Acuity (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: